Target intelligence / Profile preview

Cochlear supporting cell

Molecular classification
Other
01

Overview

Cochlear supporting cells are a heterogeneous population of non-sensory cells within the organ of Corti, including Deiters', pillar, Hensen's, and Claudius cells. They provide essential structural, metabolic, and homeostatic support to the sensory hair cells, which are responsible for converting sound vibrations into neural signals (Wan et al., 2013). A critical function of these cells is the maintenance of the endolymphatic potential through potassium ion recycling, a process vital for the sensitivity of hearing (Zheng et al., 2000). While mammalian cochlear supporting cells do not naturally regenerate lost hair cells, certain subpopulations, such as those expressing the Lgr5 marker, possess latent progenitor-like properties (McLean et al., 2017). In regenerative medicine, these cells are targeted to treat sensorineural hearing loss by inducing their conversion into new sensory hair cells. Pharmacological interventions often involve the use of Notch inhibitors, such as LY3056480, or Wnt signaling activators to trigger trans-differentiation or proliferation (Maass et al., 2015). However, therapeutic development faces significant challenges, including the risk of disrupting the cochlea's delicate structural architecture and the potential for off-target effects from modulating fundamental developmental pathways (Tona et al., 2014). Successful targeting of cochlear supporting cells represents a promising frontier for restoring hearing in patients with permanent auditory deficits.

Other names
Deiters' cellPillar cellHensen's cellClaudius cellInner phalangeal cellBorder cell
02

Mechanism of action

Induction of trans-differentiation into sensory hair cells via Notch signaling inhibition or Wnt signaling activation; stimulation of progenitor cell proliferation followed by differentiation.

03

Biological functions

Structural supportIon homeostasisCellular regenerationMetabolic supportPotassium recycling
04

Disease associations

Sensorineural hearing lossPresbycusisOtotoxicity-induced hearing loss
05

Safety considerations

Loss of structural integrity of the organ of CortiPotential for oncogenic transformation due to Wnt activationSystemic toxicity from Notch inhibitionRisk of permanent hearing threshold shift if cellular architecture is disrupted
06

Interacting drugs

LY3056480

4 more in the full profile.

07

Biomarkers

Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5)SRY-box transcription factor 2 (Sox2)Jagged1Hairy and enhancer of split 1 (Hes1)Hairy and enhancer of split 5 (Hes5)

Beyond the preview

Go deeper on Cochlear supporting cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cochlear supporting cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call